Broncus Holding (HKG:2216) received marketing approval from the Zhejiang Medical Products Administration for its lung imaging processing software, BroncQCT, according to a Friday filing with the Hong Kong bourse.
The software enables lung CT scans through advanced algorithms, offering 3D reconstructions and quantitative data for diagnosis and treatment planning.